Pain, nausea and discomfort from nasal-gastric tube insertion.
Conditions
Interventions
Intervention 1: Intervention group 1: for the intervention group 15 minutes before NG tube placement, 10 mg Ondansetron (manufactured by Alawi Pharmaceutical Company) injected intravenously. Interven
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with NG tube Indication
Exclusion criteria
Exclusion criteria: Age less than 18 years old Lack of consciousness Patients with unstable hemodynamic status (systolic blood pressure less than 90 mmHg) Having a nose bleed Anatomical problems in the nose Traumatic patients Sensitivity to Metoclopramide and Ondansetron Use of Metoclopramide and Ondansetron interfering drugs Pregnancy Patients with nausea and vomiting problem NG tube more than twice
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.;Nausea. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score.;Discomfort. Timepoint: Immediately, 30 and 60 minutes after NG tube insertion. Method of measurement: Visual Analgesic Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding after NG tube insertion. Timepoint: Immediately, 30 and 60 minutes after NG tube placement. Method of measurement: Visual Analgesic Score.;Vomiting after NG tube insertion. Timepoint: Immediately, 30 and 60 minutes after NG tube placement. Method of measurement: Visual Analgesic Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mohammad Hoseininejad
Mazandaran University of Medical Sciences
Outcome results
None listed